682 related articles for article (PubMed ID: 11420135)
1. Molecular basis of androgen insensitivity.
Brinkmann AO
Mol Cell Endocrinol; 2001 Jun; 179(1-2):105-9. PubMed ID: 11420135
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of androgen insensitivity.
Brinkmann A; Jenster G; Ris-Stalpers C; van der Korput H; Brüggenwirth H; Boehmer A; Trapman J
Steroids; 1996 Apr; 61(4):172-5. PubMed ID: 8732995
[TBL] [Abstract][Full Text] [Related]
3. Genotype versus phenotype in families with androgen insensitivity syndrome.
Boehmer AL; Brinkmann O; Brüggenwirth H; van Assendelft C; Otten BJ; Verleun-Mooijman MC; Niermeijer MF; Brunner HG; Rouwé CW; Waelkens JJ; Oostdijk W; Kleijer WJ; van der Kwast TH; de Vroede MA; Drop SL
J Clin Endocrinol Metab; 2001 Sep; 86(9):4151-60. PubMed ID: 11549642
[TBL] [Abstract][Full Text] [Related]
4. Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene.
Melo KF; Mendonca BB; Billerbeck AE; Costa EM; Inácio M; Silva FA; Leal AM; Latronico AC; Arnhold IJ
J Clin Endocrinol Metab; 2003 Jul; 88(7):3241-50. PubMed ID: 12843171
[TBL] [Abstract][Full Text] [Related]
5. Clinical, hormonal and genetic characteristics of androgen insensitivity syndrome in 39 Chinese patients.
Liu Q; Yin X; Li P
Reprod Biol Endocrinol; 2020 Apr; 18(1):34. PubMed ID: 32345305
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor mutations.
Brinkmann AO; Jenster G; Ris-Stalpers C; van der Korput JA; Brüggenwirth HT; Boehmer AL; Trapman J
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):443-8. PubMed ID: 7626493
[TBL] [Abstract][Full Text] [Related]
7. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
Ahmed SF; Cheng A; Dovey L; Hawkins JR; Martin H; Rowland J; Shimura N; Tait AD; Hughes IA
J Clin Endocrinol Metab; 2000 Feb; 85(2):658-65. PubMed ID: 10690872
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
[TBL] [Abstract][Full Text] [Related]
10. Mutations of androgen receptor gene in androgen insensitivity syndromes.
Sultan C; Lumbroso S; Poujol N; Belon C; Boudon C; Lobaccaro JM
J Steroid Biochem Mol Biol; 1993 Nov; 46(5):519-30. PubMed ID: 8240973
[TBL] [Abstract][Full Text] [Related]
11. A clinician looks at androgen resistance.
Balducci R; Ghirri P; Brown TR; Bradford S; Boldrini A; Boscherini B; Sciarra F; Toscano V
Steroids; 1996 Apr; 61(4):205-11. PubMed ID: 8733002
[TBL] [Abstract][Full Text] [Related]
12. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
Raicu F; Giuliani R; Gatta V; Palka C; Franchi PG; Lelli-Chiesa P; Tumini S; Stuppia L
Asian J Androl; 2008 Jul; 10(4):687-91. PubMed ID: 18097502
[TBL] [Abstract][Full Text] [Related]
13. Novel point mutation in the splice donor site of exon-intron junction 6 of the androgen receptor gene in a patient with partial androgen insensitivity syndrome.
Sammarco I; Grimaldi P; Rossi P; Cappa M; Moretti C; Frajese G; Geremia R
J Clin Endocrinol Metab; 2000 Sep; 85(9):3256-61. PubMed ID: 10999818
[TBL] [Abstract][Full Text] [Related]
14. Androgen insensitivity syndrome.
Hughes IA; Werner R; Bunch T; Hiort O
Semin Reprod Med; 2012 Oct; 30(5):432-42. PubMed ID: 23044881
[TBL] [Abstract][Full Text] [Related]
15. Case Report of Male Pseudohermaphroditism (Androgen Insensitivity Syndrome): Congenital Disorder of Sexual Differentiation.
Patel K; Dessi D; Trivedi S
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116050
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular aspects of androgen receptor defects.
Wieacker PF; Knoke I; Jakubiczka S
Exp Clin Endocrinol Diabetes; 1998; 106(6):446-53. PubMed ID: 10079022
[TBL] [Abstract][Full Text] [Related]
17. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
[TBL] [Abstract][Full Text] [Related]
18. Androgen insensitivity syndrome: clinical features and molecular defects.
Galani A; Kitsiou-Tzeli S; Sofokleous C; Kanavakis E; Kalpini-Mavrou A
Hormones (Athens); 2008; 7(3):217-29. PubMed ID: 18694860
[TBL] [Abstract][Full Text] [Related]
19. The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer.
Avila DM; Zoppi S; McPhaul MJ
J Steroid Biochem Mol Biol; 2001; 76(1-5):135-42. PubMed ID: 11384871
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
